191 related articles for article (PubMed ID: 23164934)
1. Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion.
Cheung LW; Yung S; Chan TM; Leung PC; Wong AS
Mol Ther; 2013 Jan; 21(1):78-90. PubMed ID: 23164934
[TBL] [Abstract][Full Text] [Related]
2. P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin.
Cheung LW; Mak AS; Cheung AN; Ngan HY; Leung PC; Wong AS
Oncogene; 2011 Jun; 30(26):2964-74. PubMed ID: 21317933
[TBL] [Abstract][Full Text] [Related]
3. p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation.
Ip CK; Yung S; Chan TM; Tsao SW; Wong AS
Oncotarget; 2014 Oct; 5(19):9133-49. PubMed ID: 25193855
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian cancer cells in vitro and in vivo.
Li CZ; Liu B; Wen ZQ; Li HY
Folia Biol (Praha); 2008; 54(6):180-6. PubMed ID: 19393131
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
6. HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
Terri M; Sandoval P; Bontempi G; Montaldo C; Tomero-Sanz H; de Turris V; Trionfetti F; Pascual-Antón L; Clares-Pedrero I; Battistelli C; Valente S; Zwergel C; Mai A; Rosanò L; Del Pozo MÁ; Sánchez-Álvarez M; Cabañas C; Tripodi M; López-Cabrera M; Strippoli R
J Exp Clin Cancer Res; 2024 Jan; 43(1):27. PubMed ID: 38254102
[TBL] [Abstract][Full Text] [Related]
7. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro.
Strobel T; Cannistra SA
Gynecol Oncol; 1999 Jun; 73(3):362-7. PubMed ID: 10366461
[TBL] [Abstract][Full Text] [Related]
8. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
Sawada K; Mitra AK; Radjabi AR; Bhaskar V; Kistner EO; Tretiakova M; Jagadeeswaran S; Montag A; Becker A; Kenny HA; Peter ME; Ramakrishnan V; Yamada SD; Lengyel E
Cancer Res; 2008 Apr; 68(7):2329-39. PubMed ID: 18381440
[TBL] [Abstract][Full Text] [Related]
9. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
Sawada K; Radjabi AR; Shinomiya N; Kistner E; Kenny H; Becker AR; Turkyilmaz MA; Salgia R; Yamada SD; Vande Woude GF; Tretiakova MS; Lengyel E
Cancer Res; 2007 Feb; 67(4):1670-9. PubMed ID: 17308108
[TBL] [Abstract][Full Text] [Related]
10. Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion.
Chen CL; Cheung LW; Lau MT; Choi JH; Auersperg N; Wang HS; Wong AS; Leung PC
Endocrine; 2007 Jun; 31(3):311-20. PubMed ID: 17906381
[TBL] [Abstract][Full Text] [Related]
11. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis.
Slack-Davis JK; Atkins KA; Harrer C; Hershey ED; Conaway M
Cancer Res; 2009 Feb; 69(4):1469-76. PubMed ID: 19208843
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells.
Ling Poon S; Lau MT; Hammond GL; Leung PC
Endocrinology; 2011 Mar; 152(3):764-72. PubMed ID: 21239435
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway.
Kim KY; Choi KC; Auersperg N; Leung PC
Endocr Relat Cancer; 2006 Mar; 13(1):211-20. PubMed ID: 16601289
[TBL] [Abstract][Full Text] [Related]
14. Autocrine role of gonadotropin-releasing hormone and its receptor in ovarian cancer cell growth.
Kang SK; Cheng KW; Nathwani PS; Choi KC; Leung PC
Endocrine; 2000 Dec; 13(3):297-304. PubMed ID: 11216641
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.
Ojasalu K; Brehm C; Hartung K; Nischak M; Finkernagel F; Rexin P; Nist A; Pavlakis E; Stiewe T; Jansen JM; Wagner U; Gattenlöhner S; Bräuninger A; Müller-Brüsselbach S; Reinartz S; Müller R
Mol Oncol; 2020 Sep; 14(9):2142-2162. PubMed ID: 32533757
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
Chakravarty D; Roy SS; Babu CR; Dandamudi R; Curiel TJ; Vivas-Mejia P; Lopez-Berestein G; Sood AK; Vadlamudi RK
Clin Cancer Res; 2011 Apr; 17(8):2250-9. PubMed ID: 21421858
[TBL] [Abstract][Full Text] [Related]
17. Detection of gonadotropin-releasing hormone receptor and its mRNA in primary human epithelial ovarian cancers.
Chien CH; Chen CH; Lee CY; Chang TC; Chen RJ; Chow SN
Int J Gynecol Cancer; 2004; 14(3):451-8. PubMed ID: 15228417
[TBL] [Abstract][Full Text] [Related]
18. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
Nakamura K; Sawada K; Kinose Y; Yoshimura A; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Morishige KI; Kurachi H; Lengyel E; Kimura T
Mol Cancer Res; 2017 Jan; 15(1):78-92. PubMed ID: 27758876
[TBL] [Abstract][Full Text] [Related]
19. Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.
Rosanò L; Spinella F; Di Castro V; Dedhar S; Nicotra MR; Natali PG; Bagnato A
Mol Cancer Ther; 2006 Apr; 5(4):833-42. PubMed ID: 16648553
[TBL] [Abstract][Full Text] [Related]
20. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
Yagi H; Yotsumoto F; Miyamoto S
Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]